Objective To compare the efficacy of different statin treatments by intensity on levels of non-
high density lipoprotein cholesterol (non-HDL-C) for the prevention of cardiovascular …

Background. The effect of statins on CIMT progression and C-reactive protein (CRP) in
T2DM patients is widely reported. However, some studies demonstrated no effect of statins …

Methods In this prospective, open-label randomized trial, group A was given rosuvastatin 40
mg daily and group B was given atorvastatin 20 mg daily along with standard post-ACS …

Background Metformin, an anti‐diabetes drug, is always used as a first‐line agent for the
management of T2DM. This meta‐analysis was conducted to investigate whether CRP was …

Background/Objectives: Psoriasis is a chronic inflammatory disease that significantly
impacts physical and emotional health. Statins, primarily used as lipid-lowering drugs, have …

Introduction Atherosclerosis mediated by inflammatory markers is the corner stone in the
pathology of coronary artery disease (CAD). Hyperlipidemia, one of the risk factors is treated …

In addition to their high-intensity effects on the reduction in low-density lipoprotein (LDL)
levels, rosuvastatin and atorvastatin would be expected to also reduce small dense LDL …

По данным Всемирной организации здравоохранения, в мире ежегодно
регистрируется около 17 млн случаев смерти от сердечно-сосудистых заболеваний …

Objective Rosuvastatin is a drug used for decreasing the risk of cardiovascular
complications in type 2 diabetes mellitus (T2DM) patients. It is hypothesized that fetuin-A …

目的探讨血清超敏C 反应蛋白(hs-CRP) 与2 型糖尿病患者颈动脉粥样硬化的相关性.
方法收集83 例2 型糖尿病患者和40 例体检健康者血清, 根据患者血清低密度脂蛋白胆固醇(LDL …